Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Midostaurin in combination with intensive chemotherapy is safe and associated with improved remission rates and higher transplantation rates in first remission-a multi-center historical control study.

Berger T, Rozovski U, Moshe Y, Yaari S, Frisch A, Hellmann I, Apel A, Aviram A, Koren-Michowitz M, Yeshurun M, Ram R, Raanani P, Ofran Y, Wolach O.

Ann Hematol. 2019 Sep 11. doi: 10.1007/s00277-019-03795-8. [Epub ahead of print]

PMID:
31512015
2.

Necrotizing Hemorrhagic Gastritis following Acute Myeloid Leukemia Induction with Midostaurin: An Unexpected Complication.

Shimony S, Reiss Mintz H, Shvartser Beryozkin Y, Shoham A, Raanani P, Wolach O.

Acta Haematol. 2019 Jul 10:1-4. doi: 10.1159/000500975. [Epub ahead of print]

PMID:
31291613
3.

Blinatumomab as a bridge to further therapy in cases of overwhelming toxicity in pediatric B-cell precursor acute lymphoblastic leukemia: Report from the Israeli Study Group of Childhood Leukemia.

Elitzur S, Arad-Cohen N, Barzilai-Birenboim S, Ben-Harush M, Bielorai B, Elhasid R, Feuerstein T, Gilad G, Gural A, Kharit M, Litichever N, Nirel R, Weinreb S, Wolach O, Toren A, Izraeli S, Jacoby E.

Pediatr Blood Cancer. 2019 Oct;66(10):e27898. doi: 10.1002/pbc.27898. Epub 2019 Jul 2.

PMID:
31264788
4.

Venetoclax in patients with acute myeloid leukemia refractory to hypomethylating agents-a multicenter historical prospective study.

Ram R, Amit O, Zuckerman T, Gurion R, Raanani P, Bar-On Y, Avivi I, Wolach O.

Ann Hematol. 2019 Aug;98(8):1927-1932. doi: 10.1007/s00277-019-03719-6. Epub 2019 Jun 11.

PMID:
31187237
5.

Risk factors for mortality due to Acinetobacter baumannii bacteremia in patients with hematological malignancies - a retrospective study.

Shargian-Alon L, Gafter-Gvili A, Ben-Zvi H, Wolach O, Yeshurun M, Raanani P, Yahav D.

Leuk Lymphoma. 2019 Apr 24:1-6. doi: 10.1080/10428194.2019.1599113. [Epub ahead of print]

PMID:
31014145
6.

Anthracycline-Induced Cardiotoxicity in Acute Myeloid Leukemia Patients Who Undergo Allogeneic Hematopoietic Stem Cell Transplantation.

Pasvolsky O, Morelli O, Rozovski U, Vaturi M, Wolach O, Amitai I, Vaxman I, Ratzon R, Yeshurun M, Kornowski R, Iakobishvilli Z, Raanani P.

Clin Lymphoma Myeloma Leuk. 2019 Jul;19(7):e343-e348. doi: 10.1016/j.clml.2019.03.007. Epub 2019 Mar 11.

PMID:
30948329
7.

Autologous hematopoietic cell transplantation for AML in first remission - An abandoned practice or promising approach?

Yeshurun M, Wolach O.

Semin Hematol. 2019 Apr;56(2):139-146. doi: 10.1053/j.seminhematol.2019.01.001. Epub 2019 Feb 14. Review.

PMID:
30926090
8.

Leucocyte adhesion deficiency-A multicentre national experience.

Wolach B, Gavrieli R, Wolach O, Stauber T, Abuzaitoun O, Kuperman A, Amir Y, Stepensky P, Somech R, Etzioni A.

Eur J Clin Invest. 2019 Feb;49(2):e13047. doi: 10.1111/eci.13047. Epub 2019 Jan 4.

PMID:
30412664
9.

Targeted next generation sequencing for the diagnosis of patients with rare congenital anemias.

Shefer Averbuch N, Steinberg-Shemer O, Dgany O, Krasnov T, Noy-Lotan S, Yacobovich J, Kuperman AA, Kattamis A, Ben Barak A, Roth-Jelinek B, Chubar E, Shabad E, Dufort G, Ellis M, Wolach O, Pazgal I, Abu Quider A, Miskin H, Tamary H.

Eur J Haematol. 2018 Sep;101(3):297-304. doi: 10.1111/ejh.13097. Epub 2018 Jun 25.

PMID:
29786897
10.

Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms.

Wolach O, Sellar RS, Martinod K, Cherpokova D, McConkey M, Chappell RJ, Silver AJ, Adams D, Castellano CA, Schneider RK, Padera RF, DeAngelo DJ, Wadleigh M, Steensma DP, Galinsky I, Stone RM, Genovese G, McCarroll SA, Iliadou B, Hultman C, Neuberg D, Mullally A, Wagner DD, Ebert BL.

Sci Transl Med. 2018 Apr 11;10(436). pii: eaan8292. doi: 10.1126/scitranslmed.aan8292.

11.

Analysis of Chronic Granulomatous Disease in the Kavkazi Population in Israel Reveals Phenotypic Heterogeneity in Patients with the Same NCF1 mutation (c.579G>A).

Wolach B, Gavrieli R, de Boer M, van Leeuwen K, Wolach O, Grisaru-Soen G, Broides A, Etzioni A, Somech R, Roos D.

J Clin Immunol. 2018 Feb;38(2):193-203. doi: 10.1007/s10875-018-0475-1. Epub 2018 Feb 6.

PMID:
29411231
12.

When should patients receive consolidation chemotherapy before allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first complete remission?

Yeshurun M, Wolach O.

Curr Opin Hematol. 2018 Mar;25(2):75-80. doi: 10.1097/MOH.0000000000000410. Review.

PMID:
29283907
13.

Antibacterial prophylaxis with ciprofloxacin for patients with multiple myeloma and lymphoma undergoing autologous haematopoietic cell transplantation: a quasi-experimental single-centre before-after study.

Yeshurun M, Vaxman I, Shargian L, Yahav D, Bishara J, Pasvolsky O, Wolach O, Lahav M, Gurion R, Magen H, Vidal L, Herscovici C, Peck A, Moshe M, Sela-Navon M, Naparstek E, Raanani P, Rozovski U.

Clin Microbiol Infect. 2018 Jul;24(7):749-754. doi: 10.1016/j.cmi.2017.11.019. Epub 2017 Dec 6.

14.

Current challenges and opportunities in treating adult patients with Philadelphia-negative acute lymphoblastic leukaemia.

Wolach O, Amitai I, DeAngelo DJ.

Br J Haematol. 2017 Dec;179(5):705-723. doi: 10.1111/bjh.14916. Epub 2017 Oct 26. Review.

PMID:
29076138
15.

Characterisation of blood-derived exosomal hTERT mRNA secretion in cancer patients: a potential pan-cancer marker.

Goldvaser H, Gutkin A, Beery E, Edel Y, Nordenberg J, Wolach O, Rabizadeh E, Uziel O, Lahav M.

Br J Cancer. 2017 Jul 25;117(3):353-357. doi: 10.1038/bjc.2017.166. Epub 2017 Jun 22.

16.

Extended Small-Dose Platelet Transfusions in Multitransfused Hemato-Oncological Patients: A Single-Center Experience.

Gurevich-Shapiro A, Tzadok S, Rosenberg A, Inbal A, Bar-Natan M, Wolach O, Raanani P.

Acta Haematol. 2017;137(4):183-190. doi: 10.1159/000465510. Epub 2017 Apr 19.

PMID:
28419992
17.

Mixed-phenotype acute leukemia: current challenges in diagnosis and therapy.

Wolach O, Stone RM.

Curr Opin Hematol. 2017 Mar;24(2):139-145. doi: 10.1097/MOH.0000000000000322. Review.

PMID:
28099272
18.

Autoimmunity and Inflammation in Myelodysplastic Syndromes.

Wolach O, Stone R.

Acta Haematol. 2016;136(2):108-17. doi: 10.1159/000446062. Epub 2016 Jun 24.

19.

Allogeneic transplantation is not superior to chemotherapy in most patients over 40 years of age with Philadelphia-negative acute lymphoblastic leukemia in first remission.

Wolach O, Stevenson KE, Wadleigh M, DeAngelo DJ, Steensma DP, Ballen KK, Soiffer RJ, Antin JH, Neuberg DS, Ho VT, Stone RM.

Am J Hematol. 2016 Aug;91(8):793-9. doi: 10.1002/ajh.24410. Epub 2016 Jun 3.

20.

The effect of FLT3-ITD and NPM1 mutation on survival in intensively treated elderly patients with cytogenetically normal acute myeloid leukemia.

Rashidi A, Wolach O, El-Jawahri A, Ho VT, DiPersio JF, Soiffer R, Stone RM, Chen YB.

Leuk Lymphoma. 2016 Aug;57(8):1977-9. doi: 10.3109/10428194.2016.1161188. Epub 2016 Mar 22. No abstract available.

PMID:
27003236
21.

Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation.

Elf S, Abdelfattah NS, Chen E, Perales-Patón J, Rosen EA, Ko A, Peisker F, Florescu N, Giannini S, Wolach O, Morgan EA, Tothova Z, Losman JA, Schneider RK, Al-Shahrour F, Mullally A.

Cancer Discov. 2016 Apr;6(4):368-81. doi: 10.1158/2159-8290.CD-15-1434. Epub 2016 Mar 7.

22.

Blinatumomab for the Treatment of Philadelphia Chromosome-Negative, Precursor B-cell Acute Lymphoblastic Leukemia.

Wolach O, Stone RM.

Clin Cancer Res. 2015 Oct 1;21(19):4262-9. doi: 10.1158/1078-0432.CCR-15-0125. Epub 2015 Aug 17. Review.

23.

High-dose cytarabine as salvage therapy for relapsed or refractory acute myeloid leukemia--is more better or more of the same?

Wolach O, Itchaki G, Bar-Natan M, Yeshurun M, Ram R, Herscovici C, Shpilberg O, Douer D, Tallman MS, Raanani P.

Hematol Oncol. 2016 Mar;34(1):28-35. doi: 10.1002/hon.2191. Epub 2015 Feb 17.

PMID:
25689584
24.

How I treat mixed-phenotype acute leukemia.

Wolach O, Stone RM.

Blood. 2015 Apr 16;125(16):2477-85. doi: 10.1182/blood-2014-10-551465. Epub 2015 Jan 20.

PMID:
25605373
25.

Is it time to change conventional consolidation chemotherapy for acute myeloid leukemia in CR1?

Wolach O, Stone RM.

Curr Opin Hematol. 2015 Mar;22(2):123-31. doi: 10.1097/MOH.0000000000000119. Review.

PMID:
25594168
26.

Pharmacodynamics of cytarabine induced leucopenia: a retrospective cohort study.

Shepshelovich D, Edel Y, Goldvaser H, Dujovny T, Wolach O, Raanani P.

Br J Clin Pharmacol. 2015 Apr;79(4):685-91. doi: 10.1111/bcp.12530.

27.

Increased activity of cell membrane-associated prothrombinase, fibrinogen-like protein 2, in peripheral blood mononuclear cells of B-cell lymphoma patients.

Rabizadeh E, Cherny I, Wolach O, Sherman S, Binkovski N, Peretz A, Lederfein D, Inbal A.

PLoS One. 2014 Oct 10;9(10):e109648. doi: 10.1371/journal.pone.0109648. eCollection 2014.

28.

Adolescents and young adults with non-Hodgkin's lymphoma: slipping between the cracks.

Wolach O, Ram R.

Acta Haematol. 2014;132(3-4):279-91. doi: 10.1159/000360212. Epub 2014 Sep 10. Review.

PMID:
25228553
29.

Can flow cytometry of bone marrow aspirate predict outcome of patients with diffuse large B cell lymphoma? A retrospective single centre study.

Wolach O, Fraser A, Luchiansky M, Shapiro C, Radnay J, Shpilberg O, Lishner M, Lahav M.

Hematol Oncol. 2015 Mar;33(1):42-7. doi: 10.1002/hon.2127. Epub 2014 Jan 27.

PMID:
24470400
30.

Variable clinical expressivity of STAT3 mutation in hyperimmunoglobulin E syndrome: genetic and clinical studies of six patients.

Wolach O, Kuijpers T, Ben-Ari J, Gavrieli R, Feinstein-Goren N, Alders M, Garty BZ, Wolach B.

J Clin Immunol. 2014 Feb;34(2):163-70. doi: 10.1007/s10875-014-9988-4. Epub 2014 Jan 23.

PMID:
24452316
31.

Limited positron emission tomography-computed tomography for restaging of lymphoma: a strategy for reducing radiation exposure among patients with early-stage curable lymphoma.

Wolach O, Bernstine H, Edel Y, Bairey O, Shpilberg O, Groshar D, Lahav M.

Acta Haematol. 2014;131(4):239-44. doi: 10.1159/000354842. Epub 2013 Dec 13.

PMID:
24355975
32.

Subcutaneous versus intravenous granulocyte colony stimulating factor for the treatment of neutropenia in hospitalized hemato-oncological patients: randomized controlled trial.

Paul M, Ram R, Kugler E, Farbman L, Peck A, Leibovici L, Lahav M, Yeshurun M, Shpilberg O, Herscovici C, Wolach O, Itchaki G, Bar-Natan M, Vidal L, Gafter-Gvili A, Raanani P.

Am J Hematol. 2014 Mar;89(3):243-8. doi: 10.1002/ajh.23622.

33.

Differential downregulation of telomerase activity by bortezomib in multiple myeloma cells-multiple regulatory pathways in vitro and ex vivo.

Weiss C, Uziel O, Wolach O, Nordenberg J, Beery E, Bulvick S, Kanfer G, Cohen O, Ram R, Bakhanashvili M, Magen-Nativ H, Shilo N, Lahav M.

Br J Cancer. 2012 Nov 20;107(11):1844-52. doi: 10.1038/bjc.2012.460.

34.

Infections associated with chronic granulomatous disease: linking genetics to phenotypic expression.

Ben-Ari J, Wolach O, Gavrieli R, Wolach B.

Expert Rev Anti Infect Ther. 2012 Aug;10(8):881-94. doi: 10.1586/eri.12.77. Review.

PMID:
23030328
35.

Adolescents and young adults with acute lymphoblastic leukemia have a better outcome when treated with pediatric-inspired regimens: systematic review and meta-analysis.

Ram R, Wolach O, Vidal L, Gafter-Gvili A, Shpilberg O, Raanani P.

Am J Hematol. 2012 May;87(5):472-8. doi: 10.1002/ajh.23149. Epub 2012 Mar 3. Review.

36.

Neutropenia after rituximab treatment: new insights on a late complication.

Wolach O, Shpilberg O, Lahav M.

Curr Opin Hematol. 2012 Jan;19(1):32-8. doi: 10.1097/MOH.0b013e32834da987. Review.

PMID:
22080846
37.

Acute promyelocytic leukemia with a smoldering course associated with therapy-related myelodysplastic syndrome.

Wolach O, Yeshurun M, Amariglio N, Shpilberg O, Raanani P.

Acta Haematol. 2011;126(3):152-6. doi: 10.1159/000328997. Epub 2011 Jul 14.

PMID:
21757888
38.

Late-onset neutropenia after rituximab treatment: case series and comprehensive review of the literature.

Wolach O, Bairey O, Lahav M.

Medicine (Baltimore). 2010 Sep;89(5):308-18. doi: 10.1097/MD.0b013e3181f2caef. Review.

39.

Lymphoma and leukemia cells possess fractal dimensions that correlate with their biological features.

Mashiah A, Wolach O, Sandbank J, Uziel O, Raanani P, Lahav M.

Acta Haematol. 2008;119(3):142-50. doi: 10.1159/000125551. Epub 2008 Apr 16.

PMID:
18417956
40.

Ethnic groups and high sensitivity C-reactive protein in Israel.

Wolach O, Arbel Y, Cohen M, Goldbourt U, Rebhun U, Shapira I, Berliner S, Rogowski O.

Biomarkers. 2008 May;13(3):296-306. doi: 10.1080/13547500701800023 .

PMID:
18415802
41.

The effect of ethnic origin on pulmonary prediction equations in a Jewish immigrant population.

Steinvil A, Fireman E, Wolach O, Rebhun U, Cohen M, Shapira I, Berliner S, Rogowski O.

Respir Med. 2008 Jun;102(6):919-26. doi: 10.1016/j.rmed.2007.12.028. Epub 2008 Feb 6.

Supplemental Content

Loading ...
Support Center